People with very low levels of erythropoietin may need injections of the hormone. These injections may successfully resolve the issue, but they do carry their own risks. In this article ...

Eprex, which is marketed outside the United States, accounted for 92 percent of the cases. Almost all cases involved patients with chronic kidney disease who had received subcutaneous injections ...

Adult- IV- Initial dose: The recommended dose is 0.6 mcg/kg. Caution should be exercised in patients with history of heart disease, high blood pressure, cancer, seizures, blood cell disorder ...

EPREX, a version of the human recombinant erythropoietin ... its link to method of injection is puzzling, since the number of PRCA cases in France is 33 while Germany reported only 3 cases ...

Drug regulators in Australia and Europe have banned the subcutaneous injection of the anti-anemia drug, epoetin alfa (Eprex) due to its association with pure red cell aplasia (PRCA), but Health Canada ...

Eprex and Binocrit are available in pre‑filled syringes at net prices of £5.53 and £4.33 per 1,000 units respectively (excluding VAT; BNF, March 2014). They are administered by subcutaneous injection ...

To elucidate the safety and efficacy of exogenous erythropoietin (EPO) for the protection of photoreceptor cells in a rat model of retinal detachment (RD). Intravitreal injection of EPO 400 ng ...